<DOC>
	<DOCNO>NCT01848262</DOCNO>
	<brief_summary>Minimally invasive surfactant therapy via small vascular catheter - ECALMIST ( Early CPAP And Large Volume Minimal Invasive Surfactant Therapy ) versus InSurE ( Intubate , Surfactant Extubate ) preterm infant Respiratory Distress Syndrome ( RDS ) : A prospective randomize clinical trial .</brief_summary>
	<brief_title>ECALMIST Versus InSurE Preterm Infant &lt; 32 Weeks , Multicenter , Multinational RCT</brief_title>
	<detailed_description>After meet inclusion criterion , eligible infant randomize receive surfactant either ECALMIST InSurE method . The attend neonatologist neonatal team full discretion decide intubate extubate wean infant ventilator NCPAP . General guideline reintubation include persistent pH &lt; 7.20 , PaCO2 &gt; 65 mmHg , frequent apnea ( &gt; 2-3/hour apneic bradycardic spell responsive corrective therapy ) , frequent desaturations &gt; 3/hour respond increase FiO2 increase FiO2 100 % ) , apneas require prolong PPV . For purpose study successful outcome primary objective occur infant reintubated ventilate initial 3 day life .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>All apply : Newborn le 32 week gestation birth Postnatal age &lt; 24 hrs life Clinical diagnosis RDS Spontaneously breathe NCPAP Clinical decision give surfactant . Lack parental consent . Need mechanical ventilation Major congenital malformation</criteria>
	<gender>All</gender>
	<minimum_age>24 Weeks</minimum_age>
	<maximum_age>31 Weeks</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>ECALMIST</keyword>
	<keyword>InSurE</keyword>
	<keyword>CPAP</keyword>
	<keyword>Ventilation</keyword>
	<keyword>Vascular Catheter</keyword>
</DOC>